- Home
- LAES vs KOD Comparison
LAES vs KOD Comparison
Compare LAES & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- KOD
- Stock Information
- Founded
- LAES 2022
- KOD 2009
- Country
- LAES Switzerland
- KOD United States
- Employees
- LAES N/A
- KOD 109
- Industry
- LAES Semiconductors
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LAES Technology
- KOD Health Care
- Exchange
- LAES Nasdaq
- KOD Nasdaq
- Market Cap
- LAES 304.2M
- KOD 259.6M
- IPO Year
- LAES N/A
- KOD 2018
- Fundamental
- Price
- LAES $2.44
- KOD $3.96
- Analyst Decision
- LAES Strong Buy
- KOD Hold
- Analyst Count
- LAES 1
- KOD 3
- Target Price
- LAES $6.00
- KOD $9.00
- AVG Volume (30 Days)
- LAES 4.5M
- KOD 473.2K
- Earning Date
- LAES 05-20-2025
- KOD 05-23-2025
- Dividend Yield
- LAES N/A
- KOD N/A
- EPS Growth
- LAES N/A
- KOD N/A
- EPS
- LAES N/A
- KOD N/A
- Revenue
- LAES $10,981,000.00
- KOD N/A
- Revenue This Year
- LAES N/A
- KOD N/A
- Revenue Next Year
- LAES N/A
- KOD N/A
- P/E Ratio
- LAES N/A
- KOD N/A
- Revenue Growth
- LAES N/A
- KOD N/A
- 52 Week Low
- LAES $0.29
- KOD $1.92
- 52 Week High
- LAES $11.00
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- LAES 45.54
- KOD 53.96
- Support Level
- LAES $2.33
- KOD $3.75
- Resistance Level
- LAES $2.57
- KOD $4.30
- Average True Range (ATR)
- LAES 0.20
- KOD 0.45
- MACD
- LAES 0.00
- KOD -0.02
- Stochastic Oscillator
- LAES 28.47
- KOD 23.43
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.